VIEMED HEALTHCARE, INC. (VMD) Shareholder Equity
- 2026-06-30: Common Stock, Value, IssuedUSD $17.98M; Additional Paid in Capital, Common StockUSD $17.81M; Retained Earnings (Accumulated Deficit)USD $108.24M; Stockholders' Equity Attributable to ParentUSD $144.03M.
- 2026-03-31: Common Stock, Value, IssuedUSD $20.81M; Additional Paid in Capital, Common StockUSD $17.58M; Retained Earnings (Accumulated Deficit)USD $105.47M; Stockholders' Equity Attributable to ParentUSD $143.86M.
- 2025-12-31: Common Stock, Value, IssuedUSD $16.91M; Additional Paid in Capital, Common StockUSD $21.74M; Retained Earnings (Accumulated Deficit)USD $102.89M; Stockholders' Equity Attributable to ParentUSD $141.54M.
- 2025-09-30: Common Stock, Value, IssuedUSD $16.90M; Additional Paid in Capital, Common StockUSD $19.45M; Retained Earnings (Accumulated Deficit)USD $97.25M; Stockholders' Equity Attributable to ParentUSD $133.61M.
VIEMED HEALTHCARE, INC. Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Common Stock, Value, Issued USD | Additional Paid in Capital, Common Stock USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest USD | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition USD | APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition USD | Noncontrolling Interest, Increase from Business Combination USD | Accumulated Other Comprehensive Income (Loss), Net of Tax USD |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $17.98M | $17.81M | $108.24M | $144.03M | $145.96M | (m) | 3 month · $2.03M | (m) | (m) |
| 2026-03-31 | $20.81M | $17.58M | $105.47M | $143.86M | $145.80M | (m) | 3 month · $2.45M | (m) | (m) |
| 2025-12-31 | $16.91M | $21.74M | $102.89M | $141.54M | $143.52M | 12 month · $25.00K | 12 month · $9.11M | (m) | (m) |
| 2025-09-30 | $16.90M | $19.45M | $97.25M | $133.61M | $135.50M | 3 month · $3.00K | 3 month · $2.18M | (m) | (m) |
| 2025-06-30 | $27.79M | $18.10M | $93.84M | $139.73M | $141.62M | 3 month · $6.00K | 3 month · $2.33M | (m) | (m) |
| 2025-03-31 | $28.15M | $15.87M | $90.73M | $134.76M | $136.75M | 3 month · $16.00K | 3 month · $2.29M | (m) | (m) |
| 2024-12-31 | $23.36M | $18.34M | $89.69M | $131.39M | $133.30M | 12 month · $269.00K | 12 month · $6.02M | 12 month · $1.80M | (m) |
| 2024-09-30 | $22.75M | $16.83M | $85.38M | $124.96M | $126.80M | 3 month · $61.00K | 3 month · $1.65M | (m) | (m) |
| 2024-06-30 | $21.91M | $15.87M | $81.59M | $119.37M | $121.18M | 3 month · $59.00K | 3 month · $1.56M | 3 month · $1.80M | (m) |
| 2024-03-31 | $21.84M | $14.29M | $80.14M | $116.27M | $116.27M | 3 month · $111.00K | 3 month · $1.32M | (m) | (m) |
| 2023-12-31 | $18.70M | $15.70M | $79.50M | $113.89M | $113.89M | 12 month · $1.17M | 12 month · $4.68M | (m) | (m) |
| 2023-09-30 | $18.63M | $14.16M | $76.02M | $108.81M | $108.81M | 3 month · $263.00K | 3 month · $1.19M | (m) | (m) |
| 2023-06-30 | $17.85M | $13.49M | $73.17M | $104.50M | $104.50M | 3 month · $301.00K | 3 month · $1.17M | (m) | (m) |
| 2023-03-31 | $17.10M | $12.09M | $70.86M | $100.04M | $100.04M | 3 month · $348.00K | 3 month · $1.04M | (m) | (m) |
| 2022-12-31 | $15.12M | $12.12M | $69.85M | $97.09M | $97.09M | 12 month · $3.09M | 12 month · $2.11M | (m) | $0.00 |
| 2022-09-30 | $14.93M | $10.81M | $68.12M | $93.91M | (m) | 3 month · $767.00K | 3 month · $542.00K | (m) | $56.00K |
| 2022-06-30 | $14.35M | $9.99M | $68.94M | $93.23M | (m) | 3 month · $757.00K | 3 month · $514.00K | (m) | $-56.00K |
| 2022-03-31 | $14.35M | $8.72M | $73.09M | $96.04M | (m) | 3 month · $820.00K | 3 month · $485.00K | (m) | $-115.00K |
| 2021-12-31 | $14.01M | $7.75M | $73.33M | $94.82M | $94.82M | 12 month · $4.20M | 12 month · $953.00K | (m) | $-278.00K |
| 2021-09-30 | $13.96M | $6.50M | $69.25M | $89.38M | (m) | 3 month · $1.05M | 3 month · $251.00K | (m) | $-330.00K |
| 2021-06-30 | $13.70M | $5.46M | $67.46M | $86.26M | (m) | 3 month · $998.00K | 3 month · $238.00K | (m) | $-351.00K |
| 2021-03-31 | $13.65M | $4.22M | $65.89M | $83.42M | (m) | 3 month · $1.08M | 3 month · $229.00K | (m) | $-345.00K |
| 2020-12-31 | $9.18M | $7.32M | $65.64M | $81.69M | (m) | 12 month · $3.81M | 12 month · $1.07M | (m) | $-451.00K |
| 2020-09-30 | $9.09M | $6.02M | $60.57M | $75.20M | (m) | 3 month · $945.00K | 3 month · $289.00K | (m) | $-478.00K |
| 2020-06-30 | $8.41M | $5.45M | $57.77M | $71.13M | (m) | 3 month · $933.00K | 3 month · $263.00K | (m) | $-502.00K |
| 2020-03-31 | $6.66M | $4.25M | $38.36M | $48.80M | (m) | 3 month · $891.00K | 3 month · $260.00K | (m) | $-469.00K |
| 2019-12-31 | $3.37M | $6.38M | $34.11M | $43.70M | (m) | 12 month · $2.64M | 12 month · $1.24M | (m) | $-157.00K |
| 2019-09-30 | $3.37M | $5.47M | $31.72M | $40.33M | (m) | 3 month · $745.00K | 3 month · $319.00K | (m) | $-236.00K |
| 2019-06-30 | $2.35M | $5.06M | $28.87M | $36.14M | (m) | 3 month · $705.00K | 3 month · $329.00K | (m) | $-148.00K |
| 2019-03-31 | $2.28M | $4.07M | $27.55M | $33.89M | (m) | 3 month · $578.00K | 3 month · $302.00K | (m) | $0.00 |
| 2018-12-31 | $71.00K | $5.39M | $27.11M | $32.57M | (m) | 12 month · $802.00K | 12 month · $1.90M | (m) | $0.00 |
| 2018-09-30 | $70.00K | $4.59M | $25.74M | $30.39M | (m) | 3 month · $205.00K | 3 month · $467.00K | (m) | $0.00 |
| 2018-06-30 | $67.00K | $3.91M | $23.52M | $27.50M | (m) | 3 month · $229.00K | 3 month · $436.00K | (m) | $0.00 |
| 2018-03-31 | $67.00K | $3.25M | $21.42M | $24.74M | (m) | 3 month · $145.00K | 3 month · $416.00K | (m) | $0.00 |
| 2017-12-31 | (m) | (m) | (m) | $21.95M | (m) | (m) | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |